Evidence map›Paper›PMID 25849663›Full record

ArticlePloS one2015

Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.

Nicoletta Bianchi, Alessia Finotti, Manuela Ferracin, Ilaria Lampronti, Cristina Zuccato, Giulia Breveglieri, Eleonora Brognara, Enrica Fabbri, Monica Borgatti, Massimo Negrini and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Treatment of Erythroid Precursor Cells from β-Thalassemia Patients withInternational journal of molecular sciences · 2021
    Article
  7. Exploring epigenetic and microRNA approaches for γ-globin gene regulation.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  8. Article
  9. Article
  10. Omics Studies in Hemoglobinopathies.Molecular diagnosis & therapy · 2019
    Review
  11. MicroRNAs and Long Non-coding RNAs in Genetic Diseases.Molecular diagnosis & therapy · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Nicoletta BianchiDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Alessia FinottiDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy; Laboratory for the Development of Pharmacological and Pharmacogenomic Therapy of Thalassaemia, Biotechnology Center, Ferrara University, Ferrara, Italy.
Manuela FerracinDepartment of Morphology, Surgery and Experimental Medicine, Ferrara University, Ferrara, Italy; Laboratory for Technologies of Advanced Therapies (LTTA), Ferrara University, Ferrara, Italy.
Ilaria LamprontiDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Cristina ZuccatoDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Giulia BreveglieriDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Eleonora BrognaraDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Enrica FabbriDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Monica BorgattiDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy.
Massimo NegriniDepartment of Morphology, Surgery and Experimental Medicine, Ferrara University, Ferrara, Italy; Laboratory for Technologies of Advanced Therapies (LTTA), Ferrara University, Ferrara, Italy.
Roberto GambariDepartment of Life Sciences and Biotechnology, Ferrara University, Ferrara, Italy; Laboratory for the Development of Pharmacological and Pharmacogenomic Therapy of Thalassaemia, Biotechnology Center, Ferrara University, Ferrara, Italy.
University of Ferrara · IT

Funding

Telethon GGP10214
6 · The paper itself

Abstract

Expression and regulation of microRNAs is an emerging issue in erythroid differentiation and globin gene expression in hemoglobin disorders. In the first part of this study microarray analysis was performed both in mithramycin-induced K562 cells and erythroid precursors from healthy subjects or β-thalassemia patients producing low or high levels of fetal hemoglobin. We demonstrated that: (a) microRNA-210 expression is higher in erythroid precursors from β-thalassemia patients with high production of fetal hemoglobin; (b) microRNA-210 increases as a consequence of mithramycin treatment of K562 cells and human erythroid progenitors both from healthy and β-thalassemia subjects; (c) this increase is associated with erythroid induction and elevated expression of γ-globin genes; (d) an anti-microRNA against microRNA-210 interferes with the mithramycin-induced changes of gene expression. In the second part of the study we have obtained convergent evidences suggesting raptor mRNA as a putative target of microRNA-210. Indeed, microRNA-210 binding sites of its 3'-UTR region were involved in expression and are targets of microRNA-210-mediated modulation in a luciferase reporter assays. Furthermore, (i) raptor mRNA and protein are down-regulated upon mithramycin-induction both in K562 cells and erythroid progenitors from healthy and β-thalassemia subjects. In addition, (ii) administration of anti-microRNA-210 to K562 cells decreased endogenous microRNA-210 and increased raptor mRNA and protein expression. Finally, (iii) treatment of K562 cells with premicroRNA-210 led to a decrease of raptor mRNA and protein. In conclusion, microRNA-210 and raptor are involved in mithramycin-mediated erythroid differentiation of K562 cells and participate to the fine-tuning and control of γ-globin gene expression in erythroid precursor cells.

Indexed as

Adaptor Proteins, Signal Transducingbeta-ThalassemiaCell DifferentiationErythroid CellsFemalegamma-GlobinsGene Expression RegulationHumansK562 CellsMaleMicroRNAsPlicamycinRegulatory-Associated Protein of mTORTOR Serine-Threonine KinasesAdaptor Proteins, Signal Transducinggamma-GlobinsMicroRNAsMIRN210 microRNA, humanMTOR protein, humanPlicamycinRegulatory-Associated Protein of mTORRPTOR protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID25849663
PMCPMC4388523
OpenAlexW2053030260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.